Kestra Private Wealth Services LLC boosted its holdings in Proto Labs, Inc. (NYSE:PRLB – Get Rating) by 6.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,755 shares of the industrial products company's stock after acquiring an additional 285 shares during the quarter. Kestra Private Wealth Services LLC's holdings in Proto Labs were worth $252,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Toroso Investments LLC lifted its position in Proto Labs by 76.7% in the 1st quarter. Toroso Investments LLC now owns 17,538 shares of the industrial products company's stock valued at $928,000 after acquiring an additional 7,612 shares in the last quarter. Gabelli Funds LLC lifted its holdings in shares of Proto Labs by 17.2% during the 1st quarter. Gabelli Funds LLC now owns 16,759 shares of the industrial products company's stock valued at $887,000 after buying an additional 2,459 shares during the period. GABELLI & Co INVESTMENT ADVISERS INC. lifted its holdings in shares of Proto Labs by 36.8% during the 1st quarter. GABELLI & Co INVESTMENT ADVISERS INC. now owns 13,000 shares of the industrial products company's stock valued at $688,000 after buying an additional 3,500 shares during the period. State Street Corp lifted its holdings in shares of Proto Labs by 3.7% during the 1st quarter. State Street Corp now owns 1,035,329 shares of the industrial products company's stock valued at $54,769,000 after buying an additional 37,314 shares during the period. Finally, Disciplined Growth Investors Inc. MN lifted its holdings in shares of Proto Labs by 3.9% during the 1st quarter. Disciplined Growth Investors Inc. MN now owns 1,860,976 shares of the industrial products company's stock valued at $98,446,000 after buying an additional 69,043 shares during the period. 88.86% of the stock is owned by institutional investors.
Get
Proto Labs alerts:
Proto Labs Price Performance
NYSE:PRLB opened at $37.47 on Thursday. The firm has a market capitalization of $1.03 billion, a price-to-earnings ratio of 42.58 and a beta of 1.33. Proto Labs, Inc. has a one year low of $36.58 and a one year high of $79.27. The business has a fifty day moving average price of $43.59 and a 200-day moving average price of $46.43.
Proto Labs (NYSE:PRLB – Get Rating) last posted its quarterly earnings data on Friday, August 5th. The industrial products company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.39 by $0.07. The firm had revenue of $126.90 million during the quarter, compared to analyst estimates of $127.28 million. Proto Labs had a return on equity of 2.95% and a net
margin of 4.88%. Proto Labs's revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.47 EPS. On average, equities research analysts expect that Proto Labs, Inc. will post 0.79 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. StockNews.com raised Proto Labs from a "hold" rating to a "buy" rating in a report on Monday, August 8th. Craig Hallum lowered their price target on Proto Labs to $42.00 in a report on Monday, August 15th.
Proto Labs Profile
(Get Rating)
Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.
See Also
- Get a free copy of the StockNews.com research report on Proto Labs (PRLB)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Get Rating).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
